arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

INVO Fertility, Inc.

IVF
$1.04 ▼ -0.01 (-1.42%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
56 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
26
Health
Poor
Moderately Bearish
auto_awesome

Analytical Summary

INVO Fertility, Inc. faces fundamental challenges with weakness in Operating Margin (%). Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $1.7M
Dividend Yield
Revenue Growth 22.8%
Op. Margin -78.9%
ROIC -8.0%
FCF / Share $-1.17
Trailing P/E
Price / Book 0.1x
FCF Yield
Debt / Equity 0.04
info Valuation on last close. End-of-day price, Aug 6, 2026.

56-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$2.02M
↑ +22.8%
Net Income Profit after all expenses
$-5.54M
↑ +68.2%
Operating Margin Operating profit as % of sales
-78.9%
↑ +11.5% 2th
FCF / Share Free cash flow per share
$-1.17
↑ +54.3%
Long-Term Debt Long-term obligations
$660.16K
↓ -26.0%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
2
Financial Health
53
Cash Quality
33

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 16 years · 56 quarters